Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Substance P and neurokinin A in the cat carotid body: localization, exogenous effects and changes in content in response to arterial pO2.
Spinal cord compression due to epidural extramedullary haematopoiesis in thalassaemia: MRI.
HLA-B37 Antigen
Increased secretory capacity of mouse adrenal chromaffin cells by chronic intermittent hypoxia: involvement of protein kinase C.
Design issues and outcomes in IBD clinical trials.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Design issues and outcomes in IBD clinical trials.
Design issues and outcomes in IBD clinical trials. Inflamm Bowel Dis. 2005 Nov; 11 Suppl 1:S22-8.
View in:
PubMed
subject areas
Biomarkers
Clinical Trials as Topic
Endpoint Determination
Humans
Inflammatory Bowel Diseases
Phenotype
Quality of Life
Research Design
Treatment Outcome
authors with profiles
Stephen B. Hanauer